Back to Search
PHILLIP MARKS, M.D.
M.D.
Urology Physician
NPI: 1720173420IndividualAccepts Medicare
Education
R FRANKLIN UNIVERSITY OF MED & SCI/CHICAGO MEDICAL SCHOOL
Class of 1983
Research & Publications (20)
Histone deacetylase inhibitors: Potential in cancer therapy.
PMID 19459166·J Cell Biochem·2009
6-review
A pilot clinical evaluation comparing the Mitek bone-tendon-bone cross pin and bioabsorbable screw in anterior cruciate ligament reconstruction fixation, a randomized double blind controlled trial.
PMID 18304817·Knee·2008
2-rct
The American Society for Clinical Investigation--the first 100 years.
PMID 18382727·J Clin Invest·2008
8-other
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.
PMID 17211407·Nat Biotechnol·2007
6-review
Thioredoxin in cancer--role of histone deacetylase inhibitors.
PMID 17095247·Semin Cancer Biol·2006
6-review
Histone deacetylase inhibitors: discovery and development as anticancer agents.
PMID 16307490·Expert Opin Investig Drugs·2005
6-review
Histone deacetylase inhibitors in programmed cell death and cancer therapy.
PMID 15738652·Cell Cycle·2005
6-review
The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA).
PMID 15020838·Cell Cycle·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 106 W MEDICAL PARK DR, SUITE A
LEXINGTON, NC 27292 - Phone
- (336) 248-4413
Quick Facts
- NPI
- 1720173420
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile